{
  "experiment_id": "c2f33aa0d62538582d912f271db41825",
  "task_name": "broadening_of_narrow_synonyms",
  "task_hash": "a2c885aa2a82bb5b150f213062bbeb89",
  "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
  "system_instructions": "You are a metadata curation assistant. Your task is to help improve and correct metadata \naccording to the specific instructions provided for each task. Be precise, accurate, and \nfollow the guidelines carefully.\n",
  "temperature": 0.1,
  "thinking": false,
  "timestamp": "2025-11-13T05:24:38.461128",
  "task_result": {
    "task_name": "broadening_of_narrow_synonyms",
    "num_samples": 10,
    "results": [
      {
        "sample_index": 0,
        "input": {
          "diagnosis": "Neurofibromatosis type 1 microdeletion syndrome",
          "assay": "clinical whole-exome sequencing",
          "tumorType": "Plexiform neurofibroma (morphologic abnormality)"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Plexiform Neurofibroma\"\n}\n```",
          "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
          "usage": {
            "input_tokens": 3052,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 59
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-sonnet-4-5-20250929",
            "id": "msg_bdrk_01RXBqqR3WfhmLi4CxgTH1mY",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Plexiform Neurofibroma\"\n}\n```"
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3052,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 59
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "whole exome sequencing",
          "tumorType": "Plexiform Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 3052,
          "output_tokens": 59,
          "total_tokens": 3111
        }
      },
      {
        "sample_index": 1,
        "input": {
          "diagnosis": "Neurofibromatosis type 1 with optic pathway glioma",
          "assay": "Illumina whole exome sequencing ",
          "tumorType": "malignant triton tumor"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```\n\n**Explanation of corrections:**\n\n1. **diagnosis**: \"Neurofibromatosis type 1 with optic pathway glioma\" \u2192 \"Neurofibromatosis type 1\"\n   - Broadened from a specific subtype with comorbidity to the general diagnosis category that matches the controlled terminology.\n\n2. **assay**: \"Illumina whole exome sequencing \" \u2192 \"whole exome sequencing\"\n   - Removed the platform-specific vendor name \"Illumina\" and trailing space to match the broader, standardized assay term in the controlled vocabulary.\n\n3. **tumorType**: \"malignant triton tumor\" \u2192 \"Malignant Peripheral Nerve Sheath Tumor\"\n   - Malignant triton tumor is a specific subtype of MPNST (characterized by rhabdomyoblastic differentiation). Broadened to the general category \"Malignant Peripheral Nerve Sheath Tumor\" which is the standard term in the controlled vocabulary.",
          "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
          "usage": {
            "input_tokens": 3047,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 290
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-sonnet-4-5-20250929",
            "id": "msg_bdrk_01PwEQnRwxrSxfncNNUXfaA5",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```\n\n**Explanation of corrections:**\n\n1. **diagnosis**: \"Neurofibromatosis type 1 with optic pathway glioma\" \u2192 \"Neurofibromatosis type 1\"\n   - Broadened from a specific subtype with comorbidity to the general diagnosis category that matches the controlled terminology.\n\n2. **assay**: \"Illumina whole exome sequencing \" \u2192 \"whole exome sequencing\"\n   - Removed the platform-specific vendor name \"Illumina\" and trailing space to match the broader, standardized assay term in the controlled vocabulary.\n\n3. **tumorType**: \"malignant triton tumor\" \u2192 \"Malignant Peripheral Nerve Sheath Tumor\"\n   - Malignant triton tumor is a specific subtype of MPNST (characterized by rhabdomyoblastic differentiation). Broadened to the general category \"Malignant Peripheral Nerve Sheath Tumor\" which is the standard term in the controlled vocabulary."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3047,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 290
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "whole exome sequencing",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
        },
        "token_usage": {
          "input_tokens": 3047,
          "output_tokens": 290,
          "total_tokens": 3337
        }
      },
      {
        "sample_index": 2,
        "input": {
          "diagnosis": "Watson Syndrome",
          "assay": "MGI whole genome sequencing",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole genome sequencing\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```\n\n**Explanation of changes:**\n\n1. **diagnosis**: \"Watson Syndrome\" \u2192 \"Neurofibromatosis type 1\"\n   - Watson Syndrome is a rare variant of Neurofibromatosis type 1 (NF1) characterized by NF1, pulmonary valvular stenosis, and intellectual disability. It is caused by mutations in the NF1 gene and is considered a specific presentation of NF1. The broader, standard term is \"Neurofibromatosis type 1\".\n\n2. **assay**: \"MGI whole genome sequencing\" \u2192 \"whole genome sequencing\"\n   - \"MGI whole genome sequencing\" is a platform-specific term (MGI refers to MGI Tech sequencing platform). The broader, standard term that captures the assay type without platform specificity is \"whole genome sequencing\".\n\n3. **tumorType**: \"Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation\" \u2192 \"Malignant Peripheral Nerve Sheath Tumor\"\n   - The input contains a highly specific subtype designation. The broader, standard term in the controlled vocabulary is \"Malignant Peripheral Nerve Sheath Tumor\", which encompasses all variants including those with mesenchymal differentiation.",
          "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
          "usage": {
            "input_tokens": 3046,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 353
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-sonnet-4-5-20250929",
            "id": "msg_bdrk_01Hiotjj3e33FiMVMfRtfzZv",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole genome sequencing\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```\n\n**Explanation of changes:**\n\n1. **diagnosis**: \"Watson Syndrome\" \u2192 \"Neurofibromatosis type 1\"\n   - Watson Syndrome is a rare variant of Neurofibromatosis type 1 (NF1) characterized by NF1, pulmonary valvular stenosis, and intellectual disability. It is caused by mutations in the NF1 gene and is considered a specific presentation of NF1. The broader, standard term is \"Neurofibromatosis type 1\".\n\n2. **assay**: \"MGI whole genome sequencing\" \u2192 \"whole genome sequencing\"\n   - \"MGI whole genome sequencing\" is a platform-specific term (MGI refers to MGI Tech sequencing platform). The broader, standard term that captures the assay type without platform specificity is \"whole genome sequencing\".\n\n3. **tumorType**: \"Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation\" \u2192 \"Malignant Peripheral Nerve Sheath Tumor\"\n   - The input contains a highly specific subtype designation. The broader, standard term in the controlled vocabulary is \"Malignant Peripheral Nerve Sheath Tumor\", which encompasses all variants including those with mesenchymal differentiation."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3046,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 353
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "whole genome sequencing",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
        },
        "token_usage": {
          "input_tokens": 3046,
          "output_tokens": 353,
          "total_tokens": 3399
        }
      },
      {
        "sample_index": 3,
        "input": {
          "diagnosis": "neurofibromatosis, familial spinal",
          "assay": "open MRI",
          "tumorType": "unknown - no information available"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"structural MRI\",\n  \"tumorType\": \"Unknown\"\n}\n```\n\n**Explanation of corrections:**\n\n1. **diagnosis**: \"neurofibromatosis, familial spinal\" \u2192 \"Neurofibromatosis type 1\"\n   - Familial spinal neurofibromatosis is a variant presentation of NF1, so the broader standard term is \"Neurofibromatosis type 1\"\n\n2. **assay**: \"open MRI\" \u2192 \"structural MRI\"\n   - \"Open MRI\" refers to the physical design of the MRI scanner, while \"structural MRI\" is the broader, standard term for the type of imaging assay being performed\n\n3. **tumorType**: \"unknown - no information available\" \u2192 \"Unknown\"\n   - Standardized to the exact controlled vocabulary term \"Unknown\" from the enum",
          "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
          "usage": {
            "input_tokens": 3034,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 224
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-sonnet-4-5-20250929",
            "id": "msg_bdrk_012qSsqwA2gpKg3AZeGoy7b3",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"structural MRI\",\n  \"tumorType\": \"Unknown\"\n}\n```\n\n**Explanation of corrections:**\n\n1. **diagnosis**: \"neurofibromatosis, familial spinal\" \u2192 \"Neurofibromatosis type 1\"\n   - Familial spinal neurofibromatosis is a variant presentation of NF1, so the broader standard term is \"Neurofibromatosis type 1\"\n\n2. **assay**: \"open MRI\" \u2192 \"structural MRI\"\n   - \"Open MRI\" refers to the physical design of the MRI scanner, while \"structural MRI\" is the broader, standard term for the type of imaging assay being performed\n\n3. **tumorType**: \"unknown - no information available\" \u2192 \"Unknown\"\n   - Standardized to the exact controlled vocabulary term \"Unknown\" from the enum"
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3034,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 224
            }
          }
        },
        "score": 0.6666666666666666,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "conventional MRI",
          "tumorType": "Unknown"
        },
        "token_usage": {
          "input_tokens": 3034,
          "output_tokens": 224,
          "total_tokens": 3258
        }
      },
      {
        "sample_index": 4,
        "input": {
          "diagnosis": "Not Applicable",
          "assay": "immunohistochemistry of skin",
          "tumorType": "Cutaneous storiform neurofibroma"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Not Applicable\",\n  \"assay\": \"immunohistochemistry\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n```\n\n**Changes made:**\n\n1. **assay**: Broadened \"immunohistochemistry of skin\" to \"immunohistochemistry\" - removed the tissue-specific qualifier to match the standard controlled terminology.\n\n2. **tumorType**: Broadened \"Cutaneous storiform neurofibroma\" to \"Cutaneous Neurofibroma\" - removed the specific histological subtype qualifier \"storiform\" to match the standard controlled terminology for cutaneous neurofibromas.\n\n3. **diagnosis**: Kept as \"Not Applicable\" - already matches the controlled terminology exactly.",
          "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
          "usage": {
            "input_tokens": 3034,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 180
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-sonnet-4-5-20250929",
            "id": "msg_bdrk_019ScsRYw97nF7rmAVxoYqXt",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Not Applicable\",\n  \"assay\": \"immunohistochemistry\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n```\n\n**Changes made:**\n\n1. **assay**: Broadened \"immunohistochemistry of skin\" to \"immunohistochemistry\" - removed the tissue-specific qualifier to match the standard controlled terminology.\n\n2. **tumorType**: Broadened \"Cutaneous storiform neurofibroma\" to \"Cutaneous Neurofibroma\" - removed the specific histological subtype qualifier \"storiform\" to match the standard controlled terminology for cutaneous neurofibromas.\n\n3. **diagnosis**: Kept as \"Not Applicable\" - already matches the controlled terminology exactly."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3034,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 180
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Not Applicable",
          "assay": "immunohistochemistry",
          "tumorType": "Cutaneous Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 3034,
          "output_tokens": 180,
          "total_tokens": 3214
        }
      },
      {
        "sample_index": 5,
        "input": {
          "diagnosis": "chromosome 17q11.2 deletion syndrome, 1.4Mb",
          "assay": "cell viability assay using Annexin V staining",
          "tumorType": "Pedunculated Cutaneous Neurofibroma"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"cell viability assay\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n```\n\n**Explanation of changes:**\n\n1. **diagnosis**: \"chromosome 17q11.2 deletion syndrome, 1.4Mb\" is a specific genetic description of Neurofibromatosis type 1 (NF1), which is caused by deletions in the NF1 gene located at chromosome 17q11.2. This was broadened to the standard term **\"Neurofibromatosis type 1\"**.\n\n2. **assay**: \"cell viability assay using Annexin V staining\" is a specific method of performing a cell viability assay. The narrow, method-specific description was broadened to the general standard term **\"cell viability assay\"**.\n\n3. **tumorType**: \"Pedunculated Cutaneous Neurofibroma\" is a morphological subtype of cutaneous neurofibroma. This was broadened to the standard term **\"Cutaneous Neurofibroma\"**.",
          "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
          "usage": {
            "input_tokens": 3056,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 271
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-sonnet-4-5-20250929",
            "id": "msg_bdrk_016egS6WeitCDd5G6bdWL8qi",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"cell viability assay\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n```\n\n**Explanation of changes:**\n\n1. **diagnosis**: \"chromosome 17q11.2 deletion syndrome, 1.4Mb\" is a specific genetic description of Neurofibromatosis type 1 (NF1), which is caused by deletions in the NF1 gene located at chromosome 17q11.2. This was broadened to the standard term **\"Neurofibromatosis type 1\"**.\n\n2. **assay**: \"cell viability assay using Annexin V staining\" is a specific method of performing a cell viability assay. The narrow, method-specific description was broadened to the general standard term **\"cell viability assay\"**.\n\n3. **tumorType**: \"Pedunculated Cutaneous Neurofibroma\" is a morphological subtype of cutaneous neurofibroma. This was broadened to the standard term **\"Cutaneous Neurofibroma\"**."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3056,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 271
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "cell viability assay",
          "tumorType": "Cutaneous Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 3056,
          "output_tokens": 271,
          "total_tokens": 3327
        }
      },
      {
        "sample_index": 6,
        "input": {
          "diagnosis": "Neurofibromatosis type 1 with scoliosis",
          "assay": "anti-tag immunocytochemistry",
          "tumorType": "sessile cutaneous neurofibroma"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"immunocytochemistry\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n```",
          "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
          "usage": {
            "input_tokens": 3047,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 58
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-sonnet-4-5-20250929",
            "id": "msg_bdrk_01Q35ABQS7bZ9aFpT9aj7q7R",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"immunocytochemistry\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n```"
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3047,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 58
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "immunocytochemistry",
          "tumorType": "Cutaneous Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 3047,
          "output_tokens": 58,
          "total_tokens": 3105
        }
      },
      {
        "sample_index": 7,
        "input": {
          "diagnosis": "neurofibromatosis, peripheral type",
          "assay": "wide bore MRI",
          "tumorType": "no clear diagnosis"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"conventional MRI\",\n  \"tumorType\": \"Unknown\"\n}\n```\n\n**Explanation of corrections:**\n\n1. **diagnosis**: \"neurofibromatosis, peripheral type\" \u2192 \"Neurofibromatosis type 1\"\n   - Peripheral neurofibromatosis is the historical term for NF1, which is the standard terminology in the controlled vocabulary.\n\n2. **assay**: \"wide bore MRI\" \u2192 \"conventional MRI\"\n   - Wide bore MRI is a specific type of MRI scanner (referring to the bore diameter), but the assay type itself is conventional MRI. The controlled vocabulary uses \"conventional MRI\" as the standard term.\n\n3. **tumorType**: \"no clear diagnosis\" \u2192 \"Unknown\"\n   - When there is no clear diagnosis or the tumor type cannot be determined, the standard controlled term is \"Unknown\".",
          "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
          "usage": {
            "input_tokens": 3031,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 224
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-sonnet-4-5-20250929",
            "id": "msg_bdrk_01AFZtcUHbqtFi4rwTCwvyKy",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"conventional MRI\",\n  \"tumorType\": \"Unknown\"\n}\n```\n\n**Explanation of corrections:**\n\n1. **diagnosis**: \"neurofibromatosis, peripheral type\" \u2192 \"Neurofibromatosis type 1\"\n   - Peripheral neurofibromatosis is the historical term for NF1, which is the standard terminology in the controlled vocabulary.\n\n2. **assay**: \"wide bore MRI\" \u2192 \"conventional MRI\"\n   - Wide bore MRI is a specific type of MRI scanner (referring to the bore diameter), but the assay type itself is conventional MRI. The controlled vocabulary uses \"conventional MRI\" as the standard term.\n\n3. **tumorType**: \"no clear diagnosis\" \u2192 \"Unknown\"\n   - When there is no clear diagnosis or the tumor type cannot be determined, the standard controlled term is \"Unknown\"."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3031,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 224
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "conventional MRI",
          "tumorType": "Unknown"
        },
        "token_usage": {
          "input_tokens": 3031,
          "output_tokens": 224,
          "total_tokens": 3255
        }
      },
      {
        "sample_index": 8,
        "input": {
          "diagnosis": "acoustic neurofibromatosis",
          "assay": "RNA-seq with ribosomal RNA depletion",
          "tumorType": "Acoustic neuroma of left vestibular nerve"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"NF2-related schwannomatosis\",\n  \"assay\": \"RNA-seq\",\n  \"tumorType\": \"Schwannoma\"\n}\n```\n\n**Explanation of corrections:**\n\n1. **diagnosis**: \"acoustic neurofibromatosis\" is a narrow/outdated term for what is now classified as \"NF2-related schwannomatosis\" (formerly called Neurofibromatosis type 2). This condition is characterized by bilateral vestibular schwannomas.\n\n2. **assay**: \"RNA-seq with ribosomal RNA depletion\" is a specific technical variation of the broader standard assay type \"RNA-seq\". The ribosomal RNA depletion is a library preparation method detail, but the core assay type is RNA-seq.\n\n3. **tumorType**: \"Acoustic neuroma of left vestibular nerve\" is a narrow, anatomically-specific term. Acoustic neuromas are vestibular schwannomas, and the broader standard term from the controlled vocabulary is \"Schwannoma\". The anatomical location (left vestibular nerve) is a specific detail that falls under the general tumor type.",
          "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
          "usage": {
            "input_tokens": 3044,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 270
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-sonnet-4-5-20250929",
            "id": "msg_bdrk_01CR97w4YcwGPKG5VmZmUudM",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"NF2-related schwannomatosis\",\n  \"assay\": \"RNA-seq\",\n  \"tumorType\": \"Schwannoma\"\n}\n```\n\n**Explanation of corrections:**\n\n1. **diagnosis**: \"acoustic neurofibromatosis\" is a narrow/outdated term for what is now classified as \"NF2-related schwannomatosis\" (formerly called Neurofibromatosis type 2). This condition is characterized by bilateral vestibular schwannomas.\n\n2. **assay**: \"RNA-seq with ribosomal RNA depletion\" is a specific technical variation of the broader standard assay type \"RNA-seq\". The ribosomal RNA depletion is a library preparation method detail, but the core assay type is RNA-seq.\n\n3. **tumorType**: \"Acoustic neuroma of left vestibular nerve\" is a narrow, anatomically-specific term. Acoustic neuromas are vestibular schwannomas, and the broader standard term from the controlled vocabulary is \"Schwannoma\". The anatomical location (left vestibular nerve) is a specific detail that falls under the general tumor type."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3044,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 270
            }
          }
        },
        "score": 0.6666666666666666,
        "ground_truth": {
          "diagnosis": "NF2-related schwannomatosis",
          "assay": "RNA-seq",
          "tumorType": "schwannoma"
        },
        "token_usage": {
          "input_tokens": 3044,
          "output_tokens": 270,
          "total_tokens": 3314
        }
      },
      {
        "sample_index": 9,
        "input": {
          "diagnosis": "neurofibromatosis type 1 due to NF1 mutation or intragenic deletion",
          "assay": "CellTiter-Glo\u00ae 3D Cell Viability Assay",
          "tumorType": "Epithelioid Malignant Peripheral Nerve Sheath Tumor"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"3D microtissue viability\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```",
          "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
          "usage": {
            "input_tokens": 3077,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 66
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-sonnet-4-5-20250929",
            "id": "msg_bdrk_013zKrs3dxqvpgt37H1Svb65",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"3D microtissue viability\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```"
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3077,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 66
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "3D microtissue viability",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
        },
        "token_usage": {
          "input_tokens": 3077,
          "output_tokens": 66,
          "total_tokens": 3143
        }
      }
    ],
    "metrics": {
      "total_samples": 10,
      "successful_runs": 10,
      "failed_runs": 0,
      "success_rate": 1.0,
      "average_score": 0.9333333333333332,
      "min_score": 0.6666666666666666,
      "max_score": 1.0,
      "num_scored": 10
    },
    "duration_seconds": 57.45557689666748,
    "token_usage": {
      "input_tokens": 30468,
      "output_tokens": 1995,
      "total_tokens": 32463
    }
  }
}